-

Susan G. Komen® Applauds U.S. Supreme Court Decision Protecting No-cost Access to Lifesaving Breast Care

Court Decision Maintains Insurance Coverage of Screening Mammograms, Genetic Testing, and Medications to Lower Breast Cancer Risk with No Patient Cost

WASHINGTON--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, commends the United States Supreme Court’s decision to overturn a lower court decision that threatened access to preventive breast care services, including screening mammography, risk-reducing medications for high-risk individuals, and genetic counseling and testing for some with a personal or family history of breast or related cancers.

The ruling in Braidwood Management, Inc., et al v. Robert Kennedy, Jr., et al upholds the Affordable Care Act’s (ACA) requirement that insurers cover services without cost-sharing that receive an A or B rating from the United States Preventive Services Taskforce (USPSTF), a decision Komen hailed as a life-saving victory for millions of Americans.

“This decision is a monumental win for public health and a critical safeguard for the 150 million Americans who depend on no-cost preventive care,” Komen stated. “Access to screening mammograms, genetic testing, and risk-reducing medications saves lives. Today, the Court affirmed that everyone deserves a fair chance at early detection and preventive care.”

Komen previously submitted an amicus curiae brief urging the Court to protect ACA provisions that have dramatically improved early detection rates and reduced late-stage breast cancer diagnoses.

“This landmark decision gives those affected by breast cancer the support and care they need in order to continue lowering mortality rates across the U.S.,” Komen continued. “We know breast cancer is most treatable when caught early. Today’s decision helps keep hope alive. We thank the Court for recognizing that preventive care is not a luxury—it is a necessity.”

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

Contacts

Media Contact:
press@komen.org

Susan G. Komen


Release Versions

Contacts

Media Contact:
press@komen.org

More News From Susan G. Komen

Susan G. Komen® To Host 2025 Race for the Cure in Detroit This September

DETROIT--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the 2025 Susan G. Komen Detroit Race for the Cure. This impactful event unites our community and raises money for the mission of Komen, supporting those affected by breast cancer. Komen aims to raise over $300,000 at the Detroit Race for the Cure, generating critical funds that allow Komen to continue...

Susan G. Komen® Announces Major Step Toward Greater Recognition of Inflammatory Breast Cancer

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, announced a major step forward in its work to detect, treat and better understand the prevalence of Inflammatory Breast Cancer (IBC). As a result of Komen’s commitment to conquering aggressive and deadly cancers, and its longstanding support of the IBC community, Komen and its collaboration partners have secured three new ICD-10-CM (International Classification of Disease, Tenth Revision, Clinical Modifica...

Lives on the Line: Komen® Speaks Out Against Reconciliation Bill as Millions Stand to Lose Coverage

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading nonprofit breast cancer organization, is deeply troubled by passage of the One Big Beautiful Bill Act which implements damaging reforms to federal health insurance programs. The Congressional Budget Office estimates these changes, combined with the failure to renew health care tax credits, could cause nearly 17 million people to lose their insurance coverage, increasing the U.S. uninsured rate by 30%. As a direct result of the action...
Back to Newsroom